GROWTH FACTORS, RECEPTORS, AND MOLECULAR ALTERATIONS IN PANCREATIC CANCER

This publication has 63 references indexed in Scilit:

• Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer
  International Journal of Cancer, 1999
• The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
  Oncogene, 1999
• Hereditary pancreatitis: new insights, new directions
  Best Practice & Research Clinical Gastroenterology, 1999
• Optimization of Treatment Conditions for Studying the Anticancer Effects of Retinoids Using Pancreatic Adenocarcinoma as a Model
  Biochemical and Biophysical Research Communications, 1999
• Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
  Journal of Clinical Investigation, 1998
• Molecular pathology of primary and metastatic ductal pancreatic lesions
  Cancer, 1997
• Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors
  Gastroenterology, 1996
• Molecular and immunochemical analyses ofRB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines
  Molecular Carcinogenesis, 1996
• Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.
  Journal of Clinical Investigation, 1992
• Increased Risk of Cancer in the Peutz–Jeghers Syndrome
  New England Journal of Medicine, 1987